Literature DB >> 15699377

Cluster headache prevalence in the Italian general population.

Paola Torelli1, Ettore Beghi, Gian Camillo Manzoni.   

Abstract

BACKGROUND: Prevalence of cluster headache (CH) is estimated at 56 to 69 per 100,000.
OBJECTIVE: To calculate the CH lifetime prevalence in a sample representative of the Italian general population over age 14 years.
METHODS: Possible CH cases according to the diagnostic criteria of the 1988 International Headache Society classification were screened from a sample of 10,071 patients (5,311 women and 4,760 men; mean age 50.4 years, SD 19.7 years) registered in the lists of seven Parma-based general practitioners (GPs), using a previously validated, specially designed, self-administered questionnaire.
RESULTS: Seven thousand five hundred twenty-two subjects (74.7%; 3,971 women and 3,551 men; mean age 50.8 years, SD 19.0 years) responded to the questionnaire in their GP's office (n = 3,338; 1,885 women and 1,453 men) or at home by mail (n = 1,914; 1,030 women and 884 men) or by phone (n = 2,270; 1,056 women and 1,214 men). Of the 111 suspected cases (76 women and 35 men), 105 were seen by a neurologist and 6 were contacted on the phone. The diagnosis of CH was confirmed in 21 (9 women and 12 men), including 7 already followed at the authors' center for CH. Seventeen patients had episodic CH, and four (all men) had chronic CH. The estimated prevalence rate was 279 per 100,000 (95% CI 173 to 427), 227 per 100,000 (95% CI 104 to 431) in women, and 338 per 100,000 (95% CI 175 to 592) in men.
CONCLUSION: These results point to a higher cluster headache lifetime prevalence than previous reports.

Entities:  

Mesh:

Year:  2005        PMID: 15699377     DOI: 10.1212/01.WNL.0000150901.47293.BC

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


  29 in total

1.  Prevalence of cluster headache in Germany: results of the epidemiological DMKG study.

Authors:  Stefan Evers; Marthe Fischera; Arne May; Klaus Berger
Journal:  J Neurol Neurosurg Psychiatry       Date:  2007-11       Impact factor: 10.154

Review 2.  Sex hormones and primary headaches other than migraine.

Authors:  Doris Lieba-Samal; Christian Wöber
Journal:  Curr Pain Headache Rep       Date:  2011-10

3.  Strictly unilateral headaches: considerations of a clinician.

Authors:  Gennaro Bussone
Journal:  Neurol Sci       Date:  2014-05       Impact factor: 3.307

Review 4.  Triptans for acute cluster headache.

Authors:  Simon Law; Sheena Derry; R Andrew Moore
Journal:  Cochrane Database Syst Rev       Date:  2010-04-14

Review 5.  Cluster headache.

Authors:  Manjit Matharu
Journal:  BMJ Clin Evid       Date:  2010-02-09

6.  Epidemiology of headaches in Tehran urban area: a population-based cross-sectional study in district 8, year 2010.

Authors:  Saeed Shahbeigi; Seyed-Mohammad Fereshtehnejad; Navid Mohammadi; Mohammad Mahdi Golmakani; Sayeh Tadayyon; Ghazal Jalilzadeh; Hossein Pakdaman
Journal:  Neurol Sci       Date:  2012-09-26       Impact factor: 3.307

Review 7.  The methodology of population surveys of headache prevalence, burden and cost: principles and recommendations from the Global Campaign against Headache.

Authors:  Lars Jacob Stovner; Mohammed Al Jumah; Gretchen L Birbeck; Gopalakrishna Gururaj; Rigmor Jensen; Zaza Katsarava; Luiz Paulo Queiroz; Ann I Scher; Redda Tekle-Haimanot; Shuu-Jiun Wang; Timothy J Steiner
Journal:  J Headache Pain       Date:  2014-01-27       Impact factor: 7.277

Review 8.  Prevalence of headache in Europe: a review for the Eurolight project.

Authors:  Lars Jacob Stovner; Colette Andree
Journal:  J Headache Pain       Date:  2010-05-16       Impact factor: 7.277

Review 9.  Epidemiology of cluster headache.

Authors:  Susan W Broner; Joshua M Cohen
Journal:  Curr Pain Headache Rep       Date:  2009-04

10.  The PACE study: past-year prevalence of tension-type headache and its subtypes in Parma's adult general population.

Authors:  T Ferrante; G C Manzoni; M Russo; A Taga; C Camarda; L Veronesi; C Pasquarella; G Sansebastiano; P Torelli
Journal:  Neurol Sci       Date:  2014-08-11       Impact factor: 3.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.